Ormat (ORA) Insider Files Form 144 to Sell 400 Shares Valued ~$38.4K

Rhea-AI Filing Summary

Form 144 notice for Ormat Technologies (ORA): The filing reports a proposed sale of 400 common shares through Morgan Stanley Smith Barney with an aggregate market value of $38,393.84, scheduled approximately on 09/30/2025. The filer states total shares outstanding of 60,723,470. The 400 shares were acquired as restricted stock on 05/08/2025 from the issuer and paid for on that date. The filing also lists two recent dispositions by the same person: 229 shares sold on 09/26/2025 for $21,716.60 and 876 shares sold on 08/27/2025 for $80,578.86. The notice includes the standard Rule 144 attestation that the seller is not aware of undisclosed material adverse information.

Positive

• Full Rule 144 disclosure provided including broker, acquisition details, and recent sales, supporting transparency
• Transaction size is immaterial relative to 60,723,470 shares outstanding, reducing market impact concerns

Negative

• None.

Insights

Securities Analyst

TL;DR: Routine insider sale notice; size is immaterial relative to outstanding shares and reflects standard Rule 144 disclosure.

The Form 144 documents a planned sale of 400 shares with a market value of about $38k scheduled for 09/30/2025. Given the issuer's reported outstanding share count of 60.7 million, this transaction is immaterial on a percentage basis (well under 0.01%). The shares were recently acquired as restricted stock on 05/08/2025, suggesting this sale likely reflects personal liquidity or planned unlocking of restricted awards rather than a signal about company fundamentals. The filing also discloses two modest prior sales (876 and 229 shares) with total proceeds of roughly $101k combined, consistent with periodic small disposals.

Compliance / Corporate Governance Expert

TL;DR: Disclosure appears procedurally complete and includes required attestation under Rule 144.

The notice identifies the broker, acquisition date and form (restricted stock), and recent sales history, meeting key Rule 144 reporting elements. The attestation that no undisclosed material adverse information is known by the seller is present. There is no indication in the filing of trading-plan adoption dates or 10b5-1 instructions, and no material concentration of shares being sold. From a governance/compliance standpoint, the filing reads as a standard, non-material disclosure.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	400	38393.84	60723470	09/30/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	05/08/2025	Restricted Stock	Issuer			400	05/08/2025	Not Applicable

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Stanley B Stern 6884 Sierra Center Pkwy Reno NV 89511-2210	Common	09/26/2025	229	21716.60
Stanley B Stern 6884 Sierra Center Pkwy Reno NV 89511-2210	Common	08/27/2025	876	80578.86

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the ORA Form 144 disclose about the planned sale?

The filing reports a proposed sale of 400 common shares via Morgan Stanley Smith Barney with an aggregate market value of $38,393.84, approximately on 09/30/2025.

When and how were the 400 ORA shares acquired?

The 400 shares were acquired as restricted stock on 05/08/2025 from the issuer, with payment dated 05/08/2025.

Has the filer sold other ORA shares recently?

Yes. The filer sold 876 shares on 08/27/2025 for $80,578.86 and 229 shares on 09/26/2025 for $21,716.60.

How large is the proposed sale compared with ORA's outstanding shares?

The proposed 400-share sale is very small versus the reported 60,723,470 shares outstanding (well under 0.01% of outstanding shares).

Does the filing indicate any undisclosed material information about Ormat?

The filer signed the standard attestation stating they do not know any material adverse information regarding the issuer that has not been publicly disclosed.